Science Translational Medicine · 2020 · 139 citations · 73 references
MedicineCancer BiologyOncologyChemotherapyMolecular OncologyTumor MicroenvironmentCancer Cell SignalingCancer ProgressionCancer Stem Cell BiologyCancer Stem CellsCancer TranscriptomicsWnt SignalingGlioblastoma Therapeutic ResistanceGlioblastoma Tumor BiologyStemness AcquisitionTherapeutic Resistance MechanismsTranscriptome AnalysisTumor Microenvironment-mediated ResistanceTumor ResistanceWnt In Cancer
and Wnt signaling activation, inducing multidrug resistance-associated protein-1(MRP-1) expression and leading to EC stemness-like activation and chemoresistance. Last, genetic ablation of β-catenin in ECs overcome GBM tumor resistance to temozolomide (TMZ) chemotherapy in vivo. Combination of Wnt inhibition and TMZ chemotherapy eliminated tumor-associated ECs, inhibited GBM growth, and increased mouse survival. These findings identified a cell plasticity-based, microenvironment-dependent mechanism that controls tumor chemoresistance, and suggest that targeting Wnt/β-catenin-mediated EC transformation and stemness activation may overcome therapeutic resistance in GBM.
73
Radiotherapy plus Concomitant and Adjuvant Temozolomide for Glioblastoma
Roger Stupp, Warren Mason, Martin J. van den Bent et al. · New England Journal of Medicine · 2005 · 21.6K citations · Full text
Glioma stem cells promote radioresistance by preferential activation of the DNA damage response
Shideng Bao, Qiulian Wu, Roger E. McLendon et al. · Nature · 2006 · 6.4K citations
Medicine, Cancer Biology, Oncology +16
A Randomized Trial of Bevacizumab for Newly Diagnosed Glioblastoma
Mark R. Gilbert, James J. Dignam, Terri S. Armstrong et al. · New England Journal of Medicine · 2014 · 2.8K citations · Full text
Medicine, Oncology, Pharmacotherapy +17
A restricted cell population propagates glioblastoma growth after chemotherapy
Jian Chen, Yanjiao Li, Tzong‐Shiue Yu et al. · Nature · 2012 · 2.3K citations
Medicine, Cancer Biology, Oncology +14